Literature DB >> 9062388

Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64.

R Navab1, J S Mort, P Brodt.   

Abstract

Cysteine proteinases, in particular cathepsins B and L, have been implicated in tumor invasion and are thought to be important mediators of metastasis. Using two clonal sublines of the Lewis lung carcinoma with distinct patterns of metastasis, we previously reported that H-59 carcinoma cells, which are highly invasive and preferentially metastatic to the liver, express high levels of cathepsin L and lower levels of cathepsin B whereas M-27 cells which are less invasive and only moderately metastatic to the lung express cathepsin B only. In the present study, the role of these enzymes in invasion and metastasis, in particular the involvement of cysteine proteinases in liver metastasis of H-59 cells was further investigated. Using a reconstituted basement membrane (Matrigel) invasion assay we found that the cysteine proteinase inhibitor, E-64, blocked the invasion of H-59 cells under conditions which did not affect cell viability. A more minor but significant inhibitory effect (up to 32%) was also seen with the propeptide of cathepsin B, implicating this enzyme in the invasion process. Furthermore, treatment of H-59 cells with E-64 inhibited experimental liver metastases formation by up to 90%. On the other hand, invasion of M-27 cells could not be blocked by cysteine proteinase inhibitors even under conditions which resulted in complete abrogation of intracellular enzymatic activity, as assessed using synthetic substrates. Together, these results confirm our previous conclusion that the two carcinoma sublines utilize distinct proteolytic mechanisms for invasion and identify the cysteine proteinases as key mediators of H-59 carcinoma invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9062388     DOI: 10.1023/a:1018496625936

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  36 in total

1.  Metalloproteinases and cancer invasion and metastasis.

Authors:  G Murphy; J J Reynolds; R M Hembry
Journal:  Int J Cancer       Date:  1989-10-15       Impact factor: 7.396

Review 2.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

3.  Proteoglycan- and collagen-degrading enzymes from human interleukin 1-stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents.

Authors:  G DiPasquale; R Caccese; R Pasternak; J Conaty; S Hubbs; K Perry
Journal:  Proc Soc Exp Biol Med       Date:  1986-11

4.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

5.  Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues.

Authors:  M R Buck; D G Karustis; N A Day; K V Honn; B F Sloane
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

6.  Human cathepsin O. Molecular cloning from a breast carcinoma, production of the active enzyme in Escherichia coli, and expression analysis in human tissues.

Authors:  G Velasco; A A Ferrando; X S Puente; L M Sánchez; C López-Otín
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

7.  Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s).

Authors:  S M Redwood; B C Liu; R E Weiss; D E Hodge; M J Droller
Journal:  Cancer       Date:  1992-03-01       Impact factor: 6.860

8.  Differences in the repertoires of basement membrane degrading enzymes in two carcinoma sublines with distinct patterns of site-selective metastasis.

Authors:  P Brodt; R Reich; L A Moroz; A F Chambers
Journal:  Biochim Biophys Acta       Date:  1992-06-09

9.  Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate.

Authors:  S Koop; I C MacDonald; K Luzzi; E E Schmidt; V L Morris; M Grattan; R Khokha; A F Chambers; A C Groom
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

10.  Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene.

Authors:  B F Sloane; K Moin; M Sameni; L R Tait; J Rozhin; G Ziegler
Journal:  J Cell Sci       Date:  1994-02       Impact factor: 5.285

View more
  8 in total

1.  Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model.

Authors:  Benelita Tina Elie; Vasilena Gocheva; Tanaya Shree; Stacie A Dalrymple; Leslie J Holsinger; Johanna A Joyce
Journal:  Biochimie       Date:  2010-05-04       Impact factor: 4.079

Review 2.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

3.  Cathepsin B expression and survival in colon cancer: implications for molecular detection of neoplasia.

Authors:  Andrew T Chan; Yoshifumi Baba; Kaori Shima; Katsuhiko Nosho; Daniel C Chung; Kenneth E Hung; Umar Mahmood; Karen Madden; Kirtland Poss; Audrey Ranieri; Daniel Shue; Raju Kucherlapati; Charles S Fuchs; Shuji Ogino
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-10       Impact factor: 4.254

4.  Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner.

Authors:  Claudia D Andl; Kelsey M McCowan; Gillian L Allison; Anil K Rustgi
Journal:  Neoplasia       Date:  2010-06       Impact factor: 5.715

5.  Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B.

Authors:  C J Van Noorden; T G Jonges; J Van Marle; E R Bissell; P Griffini; M Jans; J Snel; R E Smith
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

Review 6.  Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.

Authors:  Oakley C Olson; Johanna A Joyce
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

7.  Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3.

Authors:  Dror Alishekevitz; Svetlana Gingis-Velitski; Orit Kaidar-Person; Lilach Gutter-Kapon; Sandra D Scherer; Ziv Raviv; Emmanuelle Merquiol; Yael Ben-Nun; Valeria Miller; Chen Rachman-Tzemah; Michael Timaner; Yelena Mumblat; Neta Ilan; David Loven; Dov Hershkovitz; Ronit Satchi-Fainaro; Galia Blum; Jonathan P Sleeman; Israel Vlodavsky; Yuval Shaked
Journal:  Cell Rep       Date:  2016-10-25       Impact factor: 9.423

Review 8.  Specific functions of lysosomal proteases in endocytic and autophagic pathways.

Authors:  Sabrina Müller; Julia Dennemärker; Thomas Reinheckel
Journal:  Biochim Biophys Acta       Date:  2011-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.